According to Athenex 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.0194743. At the end of 2022 the company had a P/S ratio of 0.1938.
Year | P/S ratio | Change |
---|---|---|
2022 | 0.1938 | -84.34% |
2021 | 1.24 | -82.7% |
2020 | 7.15 | -41.89% |
2019 | 12.3 | 28.93% |
2018 | 9.54 | -60.63% |
2017 | 24.2 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 1.02 | 5,122.47% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 92.5 | 474,877.79% | ๐บ๐ธ USA |